Adopted Trials - Testicular
Acronym: TE23
Full Title
Randomised phase II trial of intensive induction chemotherapy (CBOP/BEP) and standard BEP chemotherapy in poor prognosis male germ cell tumours
Treatment: Chemotherapy
Phase: 2
Current status: Open to recruitment
Chief Investigator: Dr Robbert Huddart
Type of trial: Early Phase
